Fresenius medical care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Strong organic revenue growth1 of 7% driven by all operating segments stable u.s. same market treatment development driven by accelerating patient inflow fme25+ savings of eur 58 million contributed to earnings operating income2 grew by 13% at constant currency, further driving margin expansion stable reported operating income and 20% increase in reported net income3 operating cash flow improved strongly by 75%, net leverage ratio improved to 2.7x fy 2025 outlook confirmed first tranche of announced share buyback to be initiated in august bad homburg, germany , aug. 5, 2025 /prnewswire/ -- "in the second quarter of 2025, we further improved our operational performance as strong organic revenue growth and double-digit operating income growth put us fully on track to deliver our full year 2025 financial outlook", said helen giza, chief executive officer of fresenius medical care ag. "organic revenue growth of 7% was supported by all operating segments.
FMS Ratings Summary
FMS Quant Ranking